The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 12, 2002

Filed:

Feb. 04, 1999
Applicant:
Inventors:

Andrew Baird, San Diego, CA (US);

Grai Andreason, La Jolla, CA (US);

Assignee:

Collateral Therapeutics, San Diego, CA (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07H 2/104 ; C07H 2/102 ; C12N 1/500 ; C12N 1/509 ; C12N 1/563 ;
U.S. Cl.
CPC ...
C07H 2/104 ; C07H 2/102 ; C12N 1/500 ; C12N 1/509 ; C12N 1/563 ;
Abstract

Novel forms of vascular endothelial growth factor genes and the novel proteins encoded by these genes are disclosed. More particularly, novel forms of human VEGF-A which contain exon 6 and do not contain exon 6 are disclosed. Other novel forms of human VEGF-A contain exon 6 in addition to exon 6 These novel forms of VEGF-A include VEGF-A , VEGF-A , and VEGF-A . Such novel VEGF proteins may be used in treatment of the cardiovascular system and its diseases through effects on anatomy, conduit function, and permeability, and more particularly in the treatment of cardiovascular disease by stimulating vascular cell proliferation using a growth factor, thereby stimulating endothelial cell growth and vascular permeability. The invention also relates to nucleic acids encoding such novel VEGF proteins, cells, tissues and animals containing such nucleic acids; methods of treatment using such nucleic acids; and methods relating to all of the foregoing.


Find Patent Forward Citations

Loading…